The cytoplasmic domain of rat NKR-P1 receptor interacts with the N-terminal domain of p56(lck) via cysteine residues

被引:25
作者
Campbell, KS
Giorda, R
机构
[1] Basel Institute for Immunology, Basel
[2] Laboratorio di Biologia Molecolare, Ist. Scientifico Eugenio Medea, Ass. La Nostra Famiglia, I-22040 Bosisio Parini, (CO)
[3] Basel Institute for Immunology, Grenzacherstraße 487
关键词
NKR-P1; p56(lck); lck; natural killer cells; yeast two-hybrid system;
D O I
10.1002/eji.1830270111
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NKR-P1 is a type II transmembrane protein which acts as an activation receptor on natural killer (NK) cells. The cytoplasmic domains of the CD4, CD8 and 4-1BB receptors contain the sequence Cys-X-Cys-Pro which is directly involved in coupling to another pair of cysteines in the N-terminal domain of the src family tyrosine kinase p56(lck). The cytoplasmic domain of NKR-P1 in rodents also contains the Cys-X-Cys-Pro sequence, but the capacity of the receptor to bind p56(lck) is presently unknown. We tested for direct coupling between these proteins using both protein biochemistry and the yeast two-hybrid technique. Immunoprecipitation studies showed that p56(lck) can be co-immunoprecipitated with NKR-P1 from a rat NK tumor cell line. In addition, the cytoplasmic domain of NKR-P1 interacted with the N-terminal domain of p56(lck) in yeast as assessed by reporter gene activation. Integrity of the cysteine pairs in both proteins was critical in mediating the interaction. The experiments suggest that the association of p56(lck) with NKR-P1 is somewhat weaker than the p56(lck) association with CD8 alpha, but of much lower avidity than between CD4 and p56(lck). This could reflect a higher activation threshold for the NKR-P1 and CD8 receptors, which are involved in cytolytic responses, compared to CD4 which is involved in T cell helper function.
引用
收藏
页码:72 / 77
页数:6
相关论文
共 32 条
[21]  
REYNOLDS CW, 1984, J IMMUNOL, V132, P534
[22]   VLA-4 FIBRONECTIN INTERACTION IS REQUIRED FOR THE TERMINAL DIFFERENTIATION OF HUMAN BONE-MARROW CELLS CAPABLE OF SPONTANEOUS AND HIGH-RATE IMMUNOGLOBULIN SECRETION [J].
ROLDAN, E ;
GARCIAPARDO, A ;
BRIEVA, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (06) :1739-1747
[23]   NKR-P1A IS A TARGET-SPECIFIC RECEPTOR THAT ACTIVATES NATURAL-KILLER-CELL CYTOTOXICITY [J].
RYAN, JC ;
NIEMI, EC ;
NAKAMURA, MC ;
SEAMAN, WE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1911-1915
[24]  
RYAN JC, 1991, J IMMUNOL, V147, P3244
[25]   SHORT RELATED SEQUENCES IN THE CYTOPLASMIC DOMAINS OF CD4 AND CD8 MEDIATE BINDING TO THE AMINO-TERMINAL DOMAIN OF THE P56LCK TYROSINE PROTEIN-KINASE [J].
SHAW, AS ;
CHALUPNY, J ;
WHITNEY, JA ;
HAMMOND, C ;
AMREIN, KE ;
KAVATHAS, P ;
SEFTON, BM ;
ROSE, JK .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (05) :1853-1862
[26]   CD45 - AN EMERGING ROLE AS A PROTEIN-TYROSINE-PHOSPHATASE REQUIRED FOR LYMPHOCYTE-ACTIVATION AND DEVELOPMENT [J].
TROWBRIDGE, IS ;
THOMAS, ML .
ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :85-116
[27]   INTERACTION OF THE UNIQUE N-TERMINAL REGION OF TYROSINE KINASE P56LCK WITH CYTOPLASMIC DOMAINS OF CD4 AND CD8 IS MEDIATED BY CYSTEINE MOTIFS [J].
TURNER, JM ;
BRODSKY, MH ;
IRVING, BA ;
LEVIN, SD ;
PERLMUTTER, RM ;
LITTMAN, DR .
CELL, 1990, 60 (05) :755-765
[28]   EVIDENCE FOR A REGULATORY ROLE OF THE T8 (CD8) ANTIGEN IN ANTIGEN-SPECIFIC AND ANTI-T3-(CD3)-INDUCED LYTIC ACTIVITY OF ALLOSPECIFIC CYTOTOXIC LYMPHOCYTE-T CLONES [J].
VANSEVENTER, GA ;
VANLIER, RAW ;
SPITS, H ;
IVANYI, P ;
MELIEF, CJM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (11) :1363-1371
[29]   ALLO-SKIN GRAFT-REJECTION, TUMOR REJECTION AND NATURAL-KILLER ACTIVITY IN MICE LACKING P58(LCK) [J].
WEN, T ;
ZHANG, L ;
KUNG, SKP ;
MOLINA, TJ ;
MILLER, RG ;
MAK, TW .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (11) :3155-3159
[30]   REGULATION OF T-CELL RECEPTOR EXPRESSION IN IMMATURE CD4+CD8+ THYMOCYTES BY P56(LCK) TYROSINE KINASE - BASIS FOR DIFFERENTIAL SIGNALING BY CD4 AND CD8 IN IMMATURE THYMOCYTES EXPRESSING BOTH CORECEPTOR MOLECULES [J].
WIEST, DL ;
YUAN, L ;
JEFFERSON, J ;
BENVENISTE, P ;
TSOKOS, M ;
KLAUSNER, RD ;
GLIMCHER, LH ;
SAMELSON, LE ;
SINGER, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1701-1712